NeuroSense Therapeutics (NRSN) Cash & Equivalents Growth (3y) (2023 - 2025)
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Cash & Equivalents Growth (3y) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | -25.80% |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -17.71% |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | -15.41% |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 8.23% |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -23.18% |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 47.78% |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 37.45% |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | -21.12% |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | -63.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -63.95% |
| Jun 30, 2025 | -46.50% |
| Dec 31, 2024 | 69.07% |
| Dec 31, 2023 | 71.78% |
API Access
NeuroSense Therapeutics Cash & Equivalents Growth (3y) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents-growth-3y", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-3y&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();